<?xml version="1.0" encoding="UTF-8"?>
<ref id="jns12267-bib-0014">
 <label>14</label>
 <mixed-citation publication-type="journal" id="jns12267-cit-0014">
  <string-name>
   <surname>van Schaik</surname>
   <given-names>IN</given-names>
  </string-name>, 
  <string-name>
   <surname>Bril</surname>
   <given-names>V</given-names>
  </string-name>, 
  <string-name>
   <surname>van Geloven</surname>
   <given-names>N</given-names>
  </string-name>, et al. 
  <article-title>Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double‐blind, placebo‐controlled, phase 3 trial</article-title>. 
  <source xml:lang="en">Lancet Neurol</source>. 
  <year>2017</year>;
  <volume>17</volume>:
  <fpage>35</fpage>‐
  <lpage>46</lpage>. 
  <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/s1474-4422(17)30378-2" xmlns:xlink="http://www.w3.org/1999/xlink">https://doi.org/10.1016/s1474-4422(17)30378-2</ext-link>.
  <pub-id pub-id-type="pmid">29122523</pub-id>
 </mixed-citation>
</ref>
